Abstract
Abstract Introduction: BRCA mutation testing has been recommended for targeted, individualized cancer prevention and treatment among women whose family histories or ethnic backgrounds are associated with increased risks for BRCA mutations. This study was to assess BRCA testing in different racial/ethnic groups in the US. Methods: We used data from ClinformaticsTM Data Mart (CDM) Electronic Health Records. We included 134,827 women 18-65 years old with BRCA testing results from 1/1/2015-9/1/2017. BRCA testing rates and test result positive rates were calculated by race/ethnicity. Women with positive test results had a high risk for developing susceptible cancers - breast or ovarian cancer. As we only had data through 9/1/2017, we calculated annual test rates based on data in 2016. Results: The BRCA mutation test rate in 2016 was highest among non-Hispanic Whites (582 per 100,000), while it was 313 per 100,000 in non-Hispanic Black women, 310 per 100,000 in Hispanic Women, and 281 per 100,000 in women of other races/ethnicities. Percentage of positive results was lowest among non-Hispanic White women tested (75.7%), and highest among non-Hispanic Black test takes (85.1%). After adjusting for age, region of residence, education, income, and family history of breast or ovarian cancer, adjusted odds ratio for having a positive test among non-Hispanic Black women tested vs. non-Hispanic White women tested was 1.71, 95% confidence interval 1.61-1.82, and adjusted odds ratio for Hispanics vs non-Hispanic Whites was 1.21, 95% confidence interval 1.13-1.31. Conclusions: There are significant differences in test utilization and test results. Test utilization was highest in non-Hispanic Whites, who were also less likely to have a positive test result. Non-Hispanic Black women tested were more likely to have a positive test result, suggesting a more stringent test selection criteria for this underserved population. Citation Format: Fangjian Guo, Erika L. Fuchs, Abbey B. Berenson, Yong-Fang Kuo. Racial/ethnic differences in BRCA testing and test results among adult women [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 652.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.